ReviewMolecular systems design & engineering2026
Microfluidic perspectives on chimeric antigen receptor T-cell migration in solid tumours: highlighting physical confinement as a key barrier.
Review in Molecular systems design & engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Chimeric antigen receptor (CAR) T-cell migration and infiltration into solid tumours remains a central challenge for cancer immunotherapy. While factors such as chemokine gradients, extracellular matrix (ECM) stiffness, and immunosuppressive signalling have been well-documented, the physical confinement imposed by tumour architecture is increasingly recognized as a critical barrier. Tumour-associated ECM remodelling generates micro- and nano-scale geometric constraints that significantly alter how immune cells, particularly CAR T-cells, navigate the tumour microenvironment (TME). This article argues that physical confinement merits to be positioned at the centre of the migration challenge, not as an accessory to chemical or biochemical cues. Sustained from both fundamental cell migration biology and recent engineering advances, we highlight how designing microfluidic devices with defined geometric features can uniquely capture the role of confinement in immune cell behaviour and model this challenge. By enabling precise design control over pore size, channel geometry, and nature-inspired structures, these platforms will allow researchers to decouple confinement from other overlapping variables such as stiffness.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.